New Carbetocin Study Published on Cardiac Repolarization Effects

A new publication involving carbetocin appeared in the journal Clinical and Translational Science on October 1, 2026. The study is titled "The Effect of Carbetocin on Cardiac Repolarization: A Randomized, Placebo- and Positive-Controlled QT/QTc Study in Healthy Adults." According to the listing, the study used a randomized design with both placebo and positive controls. The research involved healthy adult participants and examined QT/QTc parameters related to cardiac repolarization. Carbetocin remains classified as an unapproved compound used in research settings. No specific findings, results, or conclusions from the study are included in this report. This brief reflects only the publication details provided, including its title, journal, and date. Readers interested in the broader context of carbetocin, including its research status and background, can consult the compound overview for additional information.